Age-related macular disease: an ongoing challenge

Editorial

Alan C Bird et al. Clin Exp Ophthalmol. 2003 Dec.

. 2003 Dec;31(6):461-3.

doi: 10.1046/j.1442-9071.2003.00721.x.

No abstract available

Comment on

Iris colour, ethnic origin and progression of age-related macular degeneration.
Nicolas CM, Robman LD, Tikellis G, Dimitrov PN, Dowrick A, Guymer RH, McCarty CA. Nicolas CM, et al. Clin Exp Ophthalmol. 2003 Dec;31(6):465-9. doi: 10.1046/j.1442-9071.2003.00711.x. Clin Exp Ophthalmol. 2003. PMID: 14641151
Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital.
Essex RW, Qureshi SH, Cain MS, Harper CA, Guymer RH. Essex RW, et al. Clin Exp Ophthalmol. 2003 Dec;31(6):476-81. doi: 10.1046/j.1442-9071.2003.00714.x. Clin Exp Ophthalmol. 2003. PMID: 14641153 Clinical Trial.
Measurement of the economic impact of visual impairment from age-related macular degeneration in Australia.
Hopley C, Carter R, Mitchell P. Hopley C, et al. Clin Exp Ophthalmol. 2003 Dec;31(6):522-9. doi: 10.1046/j.1442-9071.2003.00715.x. Clin Exp Ophthalmol. 2003. PMID: 14641161